SCHEMBL6943861

SCHEMBL6943861

CC(C)C[C@@H](C(=O)NN)[C@@H](C(=O)NO)C(/C=C/c1cccc2ccccc12)(CC(C)C)S(C)(=O)=O

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 4/20 0.39
ANPEP P15144 2/20 0.38
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
SMPD2 O60906 1/20 0.34
MTNR1A P48039 1/20 0.34
MTNR1B P49286 1/20 0.34
ALDH1A1 P00352 1/20 0.33
F2 P00734 1/20 0.33
LMNA P02545 1/20 0.33
GRIK1 P39086 1/20 0.33
GRIK2 Q13002 1/20 0.33
MMP2 P08253 1/20 0.33
MMP9 P14780 1/20 0.33
MMP8 P22894 1/20 0.33
CAPN1 P07384 1/20 0.33
CTSB P07858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6942610 0.86 ADAM17 (0.46) ADAM17ANPEPMMP2MMP9MMP8
SCHEMBL4481740 0.86 ADAM17 (0.46) ADAM17ANPEPMMP2MMP9MMP8
SCHEMBL6944369 0.83 P2RX3 (0.36)
SCHEMBL6945999 0.79 ADAM17 (0.43) ADAM17ANPEPMMP2MMP9MMP8
SCHEMBL6945409 0.79 ADAM17 (0.43) ADAM17ANPEPMMP2MMP9MMP8
SCHEMBL6941767 0.79 ADAM17 (0.46) ADAM17ANPEPMMP2MMP9MMP8
SCHEMBL6937757 0.78 ADAM17 (0.34) ADAM17
SCHEMBL6942446 0.77 ADAM17 (0.46) ADAM17ANPEPMMP2MMP9MMP8
SCHEMBL6940092 0.77 ADAM17 (0.44) ADAM17ANPEPMMP2MMP9MMP8
SCHEMBL6942998 0.77 ADAM17 (0.44) ADAM17ANPEPMMP2MMP9MMP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0993442-B1 HYDRAZINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2003-04-23 EP disclosed
US-6235787-B1 ANTIINFLAMMATORY AGENTS; RHEUMATIC DISEASES; BONE DISORDERS; SKIN DISORDERS; MULTIPLE SCLEROSIS HOFFMANN-LA ROCHE INC. 2001-05-22 US disclosed